Stock AYR.A AYR WELLNESS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Ayr Wellness Inc.

Equities

AYR.A

CA05475P1099

Market Closed - Canadian Securities Exchange
Other stock markets
 03:56:04 2024-04-26 pm EDT 		5-day change 1st Jan Change
3.25 CAD +3.83% Intraday chart for Ayr Wellness Inc. +1.56% +33.74%
Mar. 27 Ayr Wellness Inc. Launches Kynd Premium Edibles in Florida and Nevada CI
Mar. 27 Ayr Wellness Inc. Announces Upsizing of Gainesville Cultivation Facility Mortgage CI

Summary

  • The company presents an interesting fundamental situation from a short-term investment perspective.

Strengths

  • The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
  • The company's share price in relation to its net book value makes it look relatively cheap.
  • Given the positive cash flows generated by its business, the company's valuation level is an asset.
  • For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
  • For several months, analysts have been revising their EPS estimates roughly upwards.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
  • Over the past four months, analysts' average price target has been revised upwards significantly.

Weaknesses

  • Low profitability weakens the company.
  • One of the major weak points of the company is its financial situation.
  • For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
  • Over the past twelve months, analysts' consensus has been significantly revised downwards.
  • Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
  • The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
  • Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.

Ratings chart - Surperformance

Sector: Healthcare Facilities & Services

1st Jan change Capi. Investor Rating ESG Refinitiv
AYR WELLNESS INC. Stock Ayr Wellness Inc.
+33.74% 261M -
ASCEND WELLNESS HOLDINGS, INC. Stock Ascend Wellness Holdings, Inc.
+31.96% 272M -
ORGANIGRAM HOLDINGS INC. Stock Organigram Holdings Inc.
+49.42% 194M
C
JUSHI HOLDINGS INC. Stock Jushi Holdings Inc.
+44.98% 131M -
IANTHUS CAPITAL HOLDINGS, INC. Stock iAnthus Capital Holdings, Inc.
-28.57% 121M - -
INTERCURE LTD. Stock InterCure Ltd.
+115.91% 119M - -
THE CANNABIST COMPANY HOLDINGS INC. Stock The Cannabist Company Holdings Inc.
-42.17% 119M
C
4FRONT VENTURES CORP. Stock 4Front Ventures Corp.
0.00% 86.82M - -
BAKHU HOLDINGS, CORP. Stock Bakhu Holdings, Corp.
+150.00% 75.33M - -
CANNARA BIOTECH INC. Stock Cannara Biotech Inc.
+1.20% 55.24M - -
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
-
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. AYR.A Stock
  4. Ratings Ayr Wellness Inc.